---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-001406"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-03-09T23:59:59+00:00"
generated_at: "2026-05-15T17:52:17.903342+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Profound Medical to present first CAPTAIN trial outcomes at EAU 2026, host investor call March 13

## Summary
- First CAPTAIN trial outcomes (TULSA vs radical prostatectomy) presented at EAU 2026 on March 13 at 9:40 a.m. EDT.
- Investor webinar at 11:30 a.m. EDT on March 13 with Dr. Laurence Klotz reviewing data and commercial implications.
- Management to participate in Roth Conference March 22-24 in Dana Point, CA; one-on-one meetings.

## SEC filing metadata
- accession: 0001171843-26-001406
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-03-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326001406/0001171843-26-001406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326001406/f8k_030926.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-001406
- JSON: https://secwatch.observer/filing/0001171843-26-001406.json
- Plain text: https://secwatch.observer/filing/0001171843-26-001406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.